Literature DB >> 19003240

Regulation of hTERT transcription: a target of cellular and viral mechanisms for immortalization and carcinogenesis.

Izumi Horikawa1, Eriko Michishita, J Carl Barrett.   

Abstract

A hallmark of human cancer cells is immortal cell growth, which is associated with telomere maintenance by telomerase. The transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is a major mechanism that negatively and positively controls telomerase activity in normal and cancer cells, respectively. A growing body of data suggests that various cellular and viral factors and pathways involved in cell senescence, immortalization and carcinogenesis act on the hTERT promoter. The activity of the hTERT promoter is regulated, either directly or through signaling pathways, by oncogene products (e.g., Myc and Ets families) and tumor suppressor proteins (e.g., BRCA1). Endogenous factors involved in the physiological repression of the hTERT gene have also been revealed by chromosome transfer experiments. The integration of viral genomes in the hTERT locus can lead to hTERT activation and telomerase induction. Here, we summarize these findings and pay special attention to recent findings with relevance to the endogenous regulatory mechanisms of hTERT transcription.

Entities:  

Year:  2004        PMID: 19003240      PMCID: PMC3449964          DOI: 10.1007/s10616-004-5122-4

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  65 in total

1.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

Review 2.  The role of promoter insertion in the induction of neoplasia.

Authors:  D R Makowski; P G Rothberg; S M Astrin
Journal:  Surv Synth Pathol Res       Date:  1984

3.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

Review 4.  Multiple pathways to cellular senescence: role of telomerase repressors.

Authors:  M Oshimura; J C Barrett
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

5.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.

Authors:  In-kyung Park; Dalong Qian; Mark Kiel; Michael W Becker; Michael Pihalja; Irving L Weissman; Sean J Morrison; Michael F Clarke
Journal:  Nature       Date:  2003-04-20       Impact factor: 49.962

6.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.

Authors:  Julie Lessard; Guy Sauvageau
Journal:  Nature       Date:  2003-04-20       Impact factor: 49.962

7.  A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.

Authors:  I S Jeon; J N Davis; B S Braun; J E Sublett; M F Roussel; C T Denny; D N Shapiro
Journal:  Oncogene       Date:  1995-03-16       Impact factor: 9.867

8.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus.

Authors:  J J Jacobs; K Kieboom; S Marino; R A DePinho; M van Lohuizen
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

9.  The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.

Authors:  Goberdhan P Dimri; Jose-Luis Martinez; Jacqueline J L Jacobs; Petra Keblusek; Koji Itahana; Maarten Van Lohuizen; Judith Campisi; David E Wazer; Vimla Band
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.

Authors:  M J Ferber; D P Montoya; C Yu; I Aderca; A McGee; E C Thorland; D M Nagorney; B S Gostout; L J Burgart; L Boix; J Bruix; B J McMahon; T H Cheung; T K H Chung; Y F Wong; D I Smith; L R Roberts
Journal:  Oncogene       Date:  2003-06-12       Impact factor: 9.867

View more
  4 in total

1.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

2.  Grainyhead-like 2 enhances the human telomerase reverse transcriptase gene expression by inhibiting DNA methylation at the 5'-CpG island in normal human keratinocytes.

Authors:  Wei Chen; Qinghua Dong; Ki-Hyuk Shin; Reuben H Kim; Ju-Eun Oh; No-Hee Park; Mo K Kang
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

3.  Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.

Authors:  Yuan Yao; Marcia Bellon; Shary N Shelton; Christophe Nicot
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

Review 4.  TERT-Regulation and Roles in Cancer Formation.

Authors:  Marta Dratwa; Barbara Wysoczańska; Piotr Łacina; Tomasz Kubik; Katarzyna Bogunia-Kubik
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.